Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Travere Therapeutics, Inc.

NASDAQ: TVTX · Life Sciences · 4 alerts · CIK 1438533

Share price
$49.70Close, Nov 16
Market cap
$4.77B
Shares outstanding
95.99MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Travere Therapeutics, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Financial Results

Travere Therapeutics Financial Results

Travere Therapeutics reported Q3 2026 financial results, highlighted by $200.2 million in FILSPARI net product sales, representing 120% year-over-year growth. The company is advancing its Phase 3 HARMONY study of pegtibatinase with topline results expected in the second half of 2027 and plans to submit an IND for civorebrutinib by year-end.

“Strong execution across our business drove another quarter of significant growth, with FILSPARI net product sales of $200 million for the quarter as we continued to expand our reach in IgAN and FSGS.”

Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics

“As I prepare to transition leadership to Bradley Campbell in December, I have never been more confident in Travere’s future, supported by an exceptional team, an expanding pipeline and a shared commitment to delivering hope to patients.”

Eric Dube, Ph.D., president and chief executive officer of Travere Therapeutics
4:05 PM ET Form 4
Insider Selling

Travere Therapeutics CEO Eric M. Dube Sells $13.1M of Stock

Eric M. Dube, CEO, sold 243,735 shares of Travere Therapeutics, Inc. at $52.97 to $55.02 a share (average $53.82) in 3 transactions, worth $13.1M in total on Oct 15, 2026. Shares held after the trade: 432,886 (-15.3%).

Value
$13.1M
Shares
243,735
Average price
$53.82
Role
CEO
Holding change
-15.3%
Trade date
Oct 15, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.